Health Policy News

News
Filter:
Show Hide
Ex: author name, topic, etc.
Ex: author name, topic, etc.
By Topic
Show Hide
  • Expanded
  • Expanded
  • Expanded
  • Expanded
  • Expanded
  • Expanded
  • Expanded
  • Expanded
By Region
Show Hide
  • Expanded
  • Expanded
  • Expanded
  • Expanded
  • Expanded
  • Expanded
By Type
Show Hide
By date
Show Hide
Many countries have taken digital epidemiology to the next level in responding to COVID-19. Focusing on core public health functions of case detection, contact tracing, and isolation and quarantine, the authors the explore ethical concerns raised by digital technologies and new data sources in public health surveillance during epidemics.

On the World Class podcast with Michael McFaul, guests David Relman and Michelle Mello say progress will likely be uneven with states each pursuing varying degrees of social distancing and shelter-in-place policies

David Studdert writes in this JAMA commentary that as antibody tests become more prevalent and people begin to self-certify, it raises a host of important legal, ethical and policy concerns.

The Stanford-CIDE Coronavirus Simulation Model — or SC-COSMO — incorporates realistic demography and patterns to investigate resource planning and policy evaluations for diverse populations and geographies in California, Mexico and India.

An estimated 4.1 million people in the United States are carrying HCV antibodies; about 2.4 million are living with the virus, according to the US Preventive Services Task Force.

FSI Senior Fellows Karen Eggleston and David Relman joined host Michael McFaul on the World Class podcast to discuss all things COVID-19 — also known as the coronavirus.